El-Sherbiny, M.; El-Sayed, R.M.; Helal, M.A.; Ibrahiem, A.T.; Elmahdi, H.S.; Eladl, M.A.; Bilay, S.E.; Alshahrani, A.M.; Tawfik, M.K.; Hamed, Z.E.;
et al. Nifuroxazide Mitigates Angiogenesis in Ehlrich’s Solid Carcinoma: Molecular Docking, Bioinformatic and Experimental Studies on Inhibition of Il-6/Jak2/Stat3 Signaling. Molecules 2021, 26, 6858.
https://doi.org/10.3390/molecules26226858
AMA Style
El-Sherbiny M, El-Sayed RM, Helal MA, Ibrahiem AT, Elmahdi HS, Eladl MA, Bilay SE, Alshahrani AM, Tawfik MK, Hamed ZE,
et al. Nifuroxazide Mitigates Angiogenesis in Ehlrich’s Solid Carcinoma: Molecular Docking, Bioinformatic and Experimental Studies on Inhibition of Il-6/Jak2/Stat3 Signaling. Molecules. 2021; 26(22):6858.
https://doi.org/10.3390/molecules26226858
Chicago/Turabian Style
El-Sherbiny, Mohamed, Rehab M. El-Sayed, Mohamed A. Helal, Afaf T. Ibrahiem, Hoda S. Elmahdi, Mohamed Ahmed Eladl, Shymaa E. Bilay, Asma M. Alshahrani, Mona K. Tawfik, Ziad E. Hamed,
and et al. 2021. "Nifuroxazide Mitigates Angiogenesis in Ehlrich’s Solid Carcinoma: Molecular Docking, Bioinformatic and Experimental Studies on Inhibition of Il-6/Jak2/Stat3 Signaling" Molecules 26, no. 22: 6858.
https://doi.org/10.3390/molecules26226858
APA Style
El-Sherbiny, M., El-Sayed, R. M., Helal, M. A., Ibrahiem, A. T., Elmahdi, H. S., Eladl, M. A., Bilay, S. E., Alshahrani, A. M., Tawfik, M. K., Hamed, Z. E., Mohamed, A. O., & Zaitone, S. A.
(2021). Nifuroxazide Mitigates Angiogenesis in Ehlrich’s Solid Carcinoma: Molecular Docking, Bioinformatic and Experimental Studies on Inhibition of Il-6/Jak2/Stat3 Signaling. Molecules, 26(22), 6858.
https://doi.org/10.3390/molecules26226858